Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $30,000.96
Shares · price: 1,584 sh · $18.94 a share
Held after: 106,374 sh
Stock: Travere Therapeutics TVTX
Person: Peter HeermaChief Commercial Officer
Trade date: 25/01/22
Filed: 25/01/23
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/23~25/02/21

Peter Heerma's recent trades

Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$525.7K
8,282 sh
$525.7K
Filed 09/17
Traded 09/17
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$10.8M
172,717 sh
$10.8M
Filed 09/16
Traded 09/16
Peter HeermaChief Commercial Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.7M
102,190 sh
$6.7M
Filed 09/15
Traded 09/15
Peter HeermaChief Commercial Officer
SellTravere Therapeutics
Sell
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Peter HeermaChief Commercial Officer
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/05
Traded 05/05